Protective Effect of Neutral Electrolyzed Saline on Gentamicin-Induced Nephrotoxicity: Evaluation of Histopathologic Parameters in a Murine Model.

Background and Objectives: Gentamicin (GM) is a nephrotoxic aminoglycoside. Neutral electrolyzed saline (SES) is a compound with anti-inflammatory, antioxidant, and immunomodulatory properties. The objective of the present study was to evaluate whether kidney damage by GM can be prevented and/or reversed through the administration of SES. Materials and Methods: The study was carried out as a prospective, single-blind, five-arm, parallel-group, randomized, preclinical trial. The nephrotoxicity model was established in male BALB/c mice by administering GM at a dose of 100 mg/kg/day intraperitoneally for 30 days, concomitantly administering (+) SES or placebo (physiologic saline solution), and then administering SES for another 30 days after the initial 30 days of GM plus SES or placebo. At the end of the test, the mice were euthanized, and renal tissues were evaluated histopathologically. Results: The GM + placebo group showed significant tubular injury, interstitial fibrosis, and increased interstitial infiltrate of inflammatory cells compared with the group without GM. Tubular injury and interstitial fibrosis were lower in the groups that received concomitant GM + SES compared with the GM + placebo group. SES administration for 30 days after the GM administration periods (GM + placebo and GM + SES for 30 days) did not reduce nephrotoxicity. Conclusions: Intraperitoneal administration of SES prevents gentamicin-induced histologic nephrotoxicity when administered concomitantly, but it cannot reverse the damage when administered later.

Systemic Administration of Neutral Electrolyzed Saline as a Novel Treatment for Rheumatoid Arthritis Reduces Mechanical and Inflammatory Damage to the Joints: Preclinical Evaluation in Mice.

Rheumatoid arthritis is globally present in about 1% of the population. This autoinflammatory disease modifies the connective tissue, causing pain and inflammation of the joints. Over time, it causes the loss of joint cartilage and bone mass, decreasing the patient's quality of life. Treatment options now available either give symptomatic alleviation or alter the disease process. Nonetheless, adherence to chronic treatment is typically limited due to adverse effects. As a result, new therapy approaches, such as systemic administration of neutral electrolyzed saline to improve patients' quality of life, are being investigated. The study is a randomized prospective preclinical trial with a single-blind and a 4-arm parallel group using a collagen-induced mice model to generate rheumatoid arthritis. It was carried out on 36 male BALB/c mice, with the primary outcome measure being a scoring system for histopathologic assessment. When all groups are compared, there are significant differences. In addition, the animal model was validated by the healthy group. The animals treated with neutral electrolyzed saline had much less cartilage degradation, bone erosion, pannus development, and inflammation than the placebo-treated mice. Serum IL-6 levels were evaluated in parallel with disease severity expressed as synovitis grading of the affected joints. Spearman's rank correlation coefficient (Rs) = 0.399 (P=0.016) between serum IL-6 levels and the synovitis grading suggests a direct correlation between IL-6 production and disease severity. An additional trial of 20 male BALB/c mice (10 treated with placebo and 10 with neutral electrolyzed saline for 30 days) showed no clinical nor histopathological evidence of adverse effects. According to histopathological and blood test results, we conclude that neutral electrolyzed saline minimizes mechanical and inflammatory damage to the joint and may be helpful as an alternative to rheumatoid arthritis therapy.

Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial.

Coronavirus disease 2019 (COVID-19) is currently the major public health problem worldwide. Neutral electrolyzed saline solution that contains reactive chlorine and oxygen species may be an effective therapeutic. In the present study, the treatment efficacy of intravenous and/or nebulized neutral electrolyzed saline combined with usual medical care vs. usual medical care alone was evaluated in ambulatory patients with COVID-19. A prospective, 2-arm, parallel-group, randomized, open-label, multi-center, phase I-II clinical trial including 214 patients was performed. The following two outcomes were evaluated during the 20-day follow-up: i) The number of patients with disease progression; and ii) the patient acceptable symptom state. Serial severe acute respiratory syndrome coronavirus 2 naso/oro-pharyngeal detection by reverse transcription-quantitative (RT-q) PCR was performed in certain patients of the experimental group. Biochemical and hematologic parameters, as well as adverse effects, were also evaluated in the experimental group. The experimental treatment decreased the risk of hospitalization by 89% [adjusted relative risk (RR)=0.11, 95% confidence interval (CI): 0.03-0.37, P<0.001] and the risk of death by 96% (adjusted RR=0.04, 95% CI: 0.01-0.42, P=0.007) and also resulted in an 18-fold higher probability of achieving an acceptable symptom state on day 5 (adjusted RR=18.14, 95% CI: 7.29-45.09, P<0.001), compared with usual medical care alone. Overall, neutral electrolyzed saline solution was better than usual medical care alone. Of the patients analyzed, >50% were negative for the virus as detected by RT-qPCR in naso/oro-pharyngeal samples on day 4, with only a small number of positive patients on day 6. Clinical improvement correlated with a decrease in C-reactive protein, aberrant monocytes and increased lymphocytes and platelets. Cortisol and testosterone levels were also evaluated and a decrease in cortisol levels and an increase in the testosterone-cortisol ratio were observed on days 2 and 4. The experimental treatment produced no serious adverse effects. In conclusion, neutral electrolyzed saline solution markedly reduced the symptomatology and risk of progression in ambulatory patients with COVID-19. The present clinical trial was registered in the Cuban public registry of clinical trials (RPCEC) database (May 5, 2020; no. TX-COVID19: RPCEC00000309).

Comparison of different extracting agents for the recovery of Pb and Zn through electrokinetic remediation of mine tailings.

This study was conducted to investigate the feasibility of Electrokinetic Remediation to remove lead and zinc from real mine tailings, collected from the Lacan's lead and zinc Mineralized Flotation Processing Plant (Markazi province, Iran). High buffering capacity, high organic matter, and heavy metal contamination were the unique characteristics of this mine tailing. Electrokinetic remediation of the mine tailings was carried out in 11 separate experiments under constant voltage gradient of 2 V/cm for 9 days. Various enhancement techniques were tested, such as 1) electrolyte conditioning using chelating agents including ethylenediaminetetraacetic acid, citric acid, acetic acid, and hydrochloric acid; 2) increasing the concentration of the catholyte solution, and 3) adding chelating agents to the soil as a pre-treatment of the tailings and the electrolyte condoning simultaneously. The concentration of each electrolyte solution was selected based on the different extraction tests that resulted in the optimal or highest extraction percentage of lead and zinc. Electrolyte conditioning, in the case of using citric acid 1 M enhanced the removal of Pb and Zn dramatically. Catholyte conditioning, using citric acid 1 M, was the most effective enhancement technique for removing Zn (38.34%); also, the best removal efficiency of Pb (51.31%) was achieved using the same electrolyte solution in both electrode chambers. Increasing the acetic acid concentration was favorable for removal of both heavy metals. Compared to catholyte conditioning, pre-treatment coupled with catholyte conditioning could not improve the removal efficiency considerably.

Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial.

Background: Coronavirus disease (COVID-19) is currently the main public health problem worldwide. The administration of neutral electrolyzed saline, a solution that contains reactive species of chlorine and oxygen (ROS), may be an effective therapeutic alternative due to its immunomodulating characteristics, in systemic inflammation control, as well as in immune response improvement, promoting control of the viral infection. The present study evaluated the efficacy of treatment with intravenous and/or nebulized neutral electrolyzed saline combined with usual medical care versus usual medical care alone, in ambulatory patients with COVID-19. Methods: A prospective, 2-arm, parallel group, randomized, open-label, phase I-II clinical trial included 39 patients in the control group (usual medical care alone) and 45 patients in the experimental group (usual medical care + intravenous and/or nebulized electrolyzed saline, with dose escalation). Two aspects were evaluated during the twenty-day follow-up: i) the number of patients with disease progression (hospitalization or death); and ii) the Patient Acceptable Symptom State (PASS), a single-question outcome that determines patient well-being thresholds for pain and function. Biochemical and hematologic parameters, as well as adverse effects, were evaluated in the experimental group. Results: The experimental treatment decreased the risk for hospitalization by 92% (adjusted RR=0.08, 95% CI: 0.01-0.50, P=0.007), with a 43-fold increase in the probability of achieving an acceptable symptom state on day 5 (adjusted RR= 42.96, 95% CI: 9.22-200.0, P<0.001). Intravenous + nebulized administration was better than nebulized administration alone, but nebulized administration was better than usual medical care alone. Clinical improvement correlated with a decrease in C-reactive protein, and aberrant monocytes and an increase of lymphocytes, and platelets. Cortisol and testosterone levels were also evaluated, observing a decrease in cortisol levels and an increment of testosterone-cortisol ratio, on days 2 and 4. Conclusions: The experimental treatment produced no serious adverse effects. In conclusion, intravenous and/or nebulized neutral electrolyzed saline importantly reduced the symptomatology and risk of progression (hospitalization and death), in ambulatory patients with COVID-19. Trial registration: Cuban Public Registry of Clinical Trials (RPCEC) Database RPCEC00000309. Registered: 05. May 2020. https://rpcec.sld.cu/en/trials/RPCEC00000309-En.

A novel cell-free formulation for the treatment of knee osteoarthritis generates better patient-reported health outcomes in more severe cases.

BACKGROUND: The bioactive cell-free formulation (BIOF2) for cartilage regeneration has shown a major therapeutic response in severe knee osteoarthritis. However, its effect on patients with mild or moderate stages of the disease has not been studied. OBJECTIVE: To evaluate the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, minimal clinically important improvement (MCII) and sleep disturbances in mild, moderate, and severe stages of knee osteoarthritis (OA) with the novel cell-free formulation treatment (BIOF2). METHODS: An open-label, nonrandomized, baseline-controlled, parallel group study on patients with mild, moderate, and severe knee OA was conducted to evaluate the effect of intra-articular administration of BIOF2. Clinical improvement was determined through the WOMAC score and MCII, whereas sleep disturbances were measured through a Likert scale questionnaire. RESULTS: At 6 months post-treatment, the mean decrease in the total WOMAC score was 16.4 +/- 4.7%, 49.9 +/- 6.4%, and 62.7 +/- 4.5% in the patients with mild, moderate, and severe disease, respectively (p < 0.001, analysis of variance test). MCII at 6 months was 18%, 78%, and 100% for mild, moderate, and severe disease, respectively (p < 0.001, likelihood-ratio χ2 test). Concerning sleep disturbances, 60% of the patients with severe OA had important sleep problems before beginning treatment, and those difficulties were overcome 6 months after treatment. Only 18% of the patients with mild disease and 16% with moderate disease had serious sleep disturbances at the beginning of the study, and there was slight improvement after treatment. No adverse events were recorded during follow-up. CONCLUSION: BIOF2 generates better patient-reported health outcomes (on pain, stiffness, function, and sleep) in the more severe cases of knee OA.

Chemical Reduction of Nitrate by Zero-Valent Iron: Shrinking-Core versus Surface Kinetics Models.

Zero valent iron (ZVI) is being used in permeable reactive barriers (PRB) for the removal of oxidant contaminants, from nitrate to chlorinated organics. A sound design of these barriers requires a good understanding of kinetics. Here we present a study of the kinetics of nitrate reduction under relatively low values of pH, from 2 to 4.5. We use a particle size of 0.42 mm, which is within the recommended size for PRBs (0.2 mm to 2.0 mm). In order to avoid possible mass-transfer limitations, a well-stirred reactor coupled with a fluidized bed reactor was used. The experiments were performed at constant pH values using a pH controller that allows to accurately track the amount of acid added. Since the reduction of H + to H 2 by the oxidation of ZVI will always be present for these pH values, blank experiments (without nitrate) were performed and the rate of this H + reduction obtained. This rate of reduction was studied using three kinetic models: a regular empirical one, the Shrinking-Core Model (SCM), and the Surface Kinetics Model (SKM). The best performance was obtained from the SKM model. Therefore, this model was also used to study the results for the nitrate reduction, also with satisfactory results. In both cases, some assumptions are introduced to maintain a moderate number of fitting parameters.

Emerging organic contaminants in wastewater: Understanding electrochemical reactors for triclosan and its by-products degradation.

Degradation technologies applied to emerging organic contaminants from human activities are one of the major water challenges in the contamination legacy. Triclosan is an emerging contaminant, commonly used as antibacterial agent in personal care products. Triclosan is stable, lipophilic and it is proved to have ecotoxicologic effects in organics. This induces great concern since its elimination in wastewater treatment plants is not efficient and its by-products (e.g. methyl-triclosan, 2,4-dichlorophenol or 2,4,6-trichlorophenol) are even more hazardous to several environmental compartments. This work provides understanding of two different electrochemical reactors for the degradation of triclosan and its derivative by-products in effluent. A batch reactor and a flow reactor (mimicking a secondary settling tank in a wastewater treatment plant) were tested with two different working anodes: Ti/MMO and Nb/BDD. The degradation efficiency and kinetics were evaluated to find the best combination of current density, electrodes and set-up design. For both reactors the best electrode combination was achieved with Ti/MMO as anode. The batch reactor at 7 mA/cm2 during 4 h attained degradation rates below the detection limit for triclosan and 2,4,6-trichlorophenol and, 94% and 43% for 2,4-dichlorophenol and methyl triclosan, respectively. The flow reactor obtained, in approximately 1 h, degradation efficiencies between 41% and 87% for the four contaminants. This study suggests an alternative technology for emerging organic contaminants degradation, since the combination of a low current density with the flow and matrix induced disturbance increases and speeds up the compounds' elimination in a real environmental matrix.

Electronic Tongue Coupled to an Electrochemical Flow Reactor for Emerging Organic Contaminants Real Time Monitoring.

Triclosan, which is a bacteriostatic used in household items, has raised health concerns, because it might lead to antimicrobial resistance and endocrine disorders in organisms. The detection, identification, and monitoring of triclosan and its by-products (methyl triclosan, 2,4-Dichlorophenol and 2,4,6-Trichlorophenol) are a growing need in order to update current water treatments and enable the continuous supervision of the contamination plume. This work presents a customized electronic tongue prototype coupled to an electrochemical flow reactor, which aims to access the monitoring of triclosan and its derivative by-products in a real secondary effluent. An electronic tongue device, based on impedance measurements and polyethylenimine/poly(sodium 4-styrenesulfonate) layer-by-layer and TiO2, ZnO and TiO2/ZnO sputtering thin films, was developed and tested to track analyte degradation and allow for analyte detection and semi-quantification. A degradation pathway trend was observable by means of principal component analysis, being the sample separation, according to sampling time, explained by 77% the total variance in the first two components. A semi-quantitative electronic tongue was attained for triclosan and methyl-triclosan. For 2,4-Dichlorophenol and 2,4,6-Trichlorophenol, the best results were achieved with only a single sensor. Finally, working as multi-analyte quantification devices, the electronic tongues could provide information regarding the degradation kinetic and concentrations ranges in a dynamic removal treatment.

Patient-reported health outcomes for severe knee osteoarthritis after conservative treatment with an intra-articular cell-free formulation for articular cartilage regeneration combined with usual medical care vs. usual medical care alone: A randomized controlled trial.

Osteoarthritis (OA) is a major public health problem characterized by joint pain, fatigue, functional limitation and decreased quality of life of the patient, which results in increased use of healthcare services and high economical costs. A promising novel bioactive cell-free formulation (BIOF2) for cartilage regeneration has recently been tested in pre-clinical and clinical trials, and has demonstrated a success rate similar to that of total joint arthroplasty for the treatment of severe knee OA. The present study evaluated the efficacy of treatment with BIOF2, by including it within a conservative regimen of 'usual medical care' of knee OA, and whether its efficacy was affected in subgroups of patients presenting with comorbidities that exacerbate OA. A prospective, randomized, 2-arm parallel group phase III clinical trial was conducted, which included 105 patients in the 'usual medical care' group (paracetamol/NSAIDs and general care provided by the family physician) and 107 patients in the BIOF2 group (usual medical care + intra-articular BIOF2 application at 0, 1 and 2 months). Two aspects were evaluated at 0, 6 and 12 months: i) Minimal clinically important improvement (MCII), based on 30% improvement of pain from the baseline; and ii) the Patient Acceptable Symptom State (PASS), a questionnaire that determines patient well-being thresholds for articular pain and function. Adverse effects and regular NSAID use were registered. At 12 months, BIOF-2 treatment produced MCII in 70% of the patients and >50% achieved PASS. Excluding the patients with class 2 obesity or malalignment conditions (genu varum or genu valgum >20 degrees), the experimental treatment produced MCII and PASS in 100 and 92% of patients, respectively, compared with 25 and 8% in the group of usual medical care (P<0.001). No patient with malalignment and treatment with BIOF2 achieved PASS. Notably, there were no serious adverse effects. To conclude, BIOF2 is a safe therapeutic alternative that is easy to implement together with usual medical care for knee OA. Trial registration: Cuban Public Registry of Clinical Trials (RPCEC) Database RPCEC00000277. Retrospectively registered June, 2018.

Modeling of electrokinetic remediation combining local chemical equilibrium and chemical reaction kinetics.

A mathematical model for reactive-transport processes in porous media is presented. The modeled system includes diffusion, electromigration and electroosmosis as the most relevant transport mechanisms and water electrolysis at the electrodes, aqueous species complexation, precipitation and dissolution as the chemical reactions taken place during the treatment time. The model is based on the local chemical equilibrium for most of the reversible chemical reactions occurring in the process. As a novel enhancement of previous models, the local chemical equilibrium reactive-transport model is combined with the solution of the transient equations for the kinetics of those chemical reactions that have representative rates in the same order than the transport mechanisms. The model is validated by comparison of simulation and experimental results for an acid-enhanced electrokinetic treatment of a real Pb-contaminated calcareous soil. The kinetics of the main pH buffering process, the calcite dissolution, was defined by a simplified empirical kinetic law. Results show that the evaluation of kinetic rate entails a significant improvement of the model prediction capability.

Modeling of electrokinetic remediation of Cd- and Pb-contaminated kaolinite.

A physiscochemical model is presented for the reactive-transport of chemical scpecies through a contaminated soil during an acid-enhanced electrokinetic remediation treatment. Numerical simulations in the specific case of the removal of cadmium and lead from spiked kaolinite, compared with experimental results from the literature. The reactive-transport based on the local chemical equilibrium assumption, including a surface complexation to model the adsorption of cations (metals and protons). Comparison of simulation results show different beavior of the target metals, as cadmium is mainly retaind by surface interaction while lead is retained by precipitation of a solid phase.

A phase I-II controlled randomized trial using a promising novel cell-free formulation for articular cartilage regeneration as treatment of severe osteoarthritis of the knee.

BACKGROUND: A promising novel cell-free bioactive formulation for articular cartilage regeneration, called BIOF2, has recently been tested in pre-clinical trials. The aim of the present study was to evaluate the efficacy and safety of BIOF2 for intra-articular application in patients with severe osteoarthritis of the knee. METHODS: A prospective, randomized, 3-arm, parallel group clinical trial was conducted. It included 24 patients with severe osteoarthritis of the knee (WOMAC score 65.9 ± 17). Before they entered the study, all the patients were under osteoarthritis control through the standard treatment with nonsteroidal anti-inflammatory drugs (NSAIDs), prescribed by their family physician. Patients were distributed into three groups of 8 patients each (intra-articular BIOF2, total joint arthroplasty, or conservative treatment with NSAIDs alone). The WOMAC score, RAPID3 score, and Rasmussen clinical score were evaluated before treatment and at months 3, 6, and 12. BIOF2 was applied at months 0, 3, and 6. Complete blood count and blood chemistry parameters were determined in the BIOF2 group before treatment, at 72 h, and at months 1, 3, 6, and 12. In addition, articular cartilage volume was evaluated (according to MRI) at the beginning of the study and at month 12. RESULTS: The NSAID group showed no improvement at follow-up. Arthroplasty and BIOF2 treatments showed significant improvement in all the scoring scales starting at month 3. There were no statistically significant differences between the BIOF2 group and the arthroplasty group at month 6 (WOMAC score: 19.3 ± 18 vs 4.3 ± 5; P = 0.24) or month 12 (WOMAC score: 15.6 ± 15 vs 15.7 ± 17; P = 1.0). Arthroplasty and BIOF2 were successful at month 12 (according to a WOMAC score: ≤ 16) in 75% of the patients and the daily use of NSAIDs was reduced, compared with the group treated exclusively with NSAIDs (RR = 0.33, 95% CI 0.12-0.87, P = 0.02. This result was the same for BIOF2 vs NSAIDs and arthroplasty vs NSAIDs). BIOF2 significantly increased the articular cartilage by 22% (26.1 ± 10 vs 31.9 ± 10 cm2, P < 0.001) and produced a significant reduction in serum lipids. BIOF2 was well tolerated, causing slight-to-moderate pain only upon application. CONCLUSIONS: The intra-articular application of the new bioactive cell-free formulation (BIOF2) was well tolerated and showed no significative differences with arthroplasty for the treatment of severe osteoarthritis of the knee. BIOF2 can regenerate articular cartilage and is an easily implemented alternative therapy for the treatment of osteoarthritis. Trial registration Cuban Public Registry of Clinical Trials (RPCEC) Database RPCEC00000250. Registered 08/15/2017-Retrospectively registered, http://rpcec.sld.cu/en/trials/RPCEC00000250-En .

Aging effects on the mobility of Pb in soil: Influence on the energy requirements in electroremediation.

This paper studies the possible differences in the behavior of lead as a contaminant in soil samples when it is present as "naturally-aged" for decades after the contamination, and when it has been spiked in the laboratory. This behavior differences are stablished mainly in two ways: as changes in the fractionation analysis obtained after a sequential extraction procedure (SEP) and as changes in the efficiency of the acid-enhanced electroremediation (EKR) technique. Additionally, aging effects have been studied for almost five years. In the case of the lead-spiked soil the influence of storage conditions on contaminant behavior have also been explored: 1) samples stored in capped containers at constant moisture conditions, and 2) samples in containers open to the atmosphere, with periods of water flooding and drying. Lab-spiked and the "naturally-aged" contaminants show very different behavior with respect not only to SEP analysis but also to EKR experiments. The soil spiked with a soluble lead salt presents a higher percent in the more mobile fractions. Regarding storage conditions, some changes were observed in the lead distribution along the vertical soil profile for samples stored in uncapped containers. The EKR results were also in agreement with those from fractionation analysis. Energy requirements for the remediation were estimated by a mathematical model with important differences obtained for the different soil samples. Results are indicating that it will be very unreliable to draw estimations for the "naturally-aged" soils from contaminant-spiked samples.

A promising novel formulation for articular cartilage regeneration: Preclinical evaluation of a treatment that produces SOX9 overexpression in human synovial fluid cells.

Osteoarthritis (OA) is a chronic disorder of synovial joints, in which there is progressive softening and disintegration of the articular cartilage. OA is the most common form of arthritis, and is the primary cause of disability and impaired quality of life in the elderly. Despite considerable medical necessity, no treatment has yet been proven to act as a disease­modifying agent that may halt or reverse the structural progression of OA. The replacement of the joint with a prosthesis appears to be the best option in the advanced stages of the disease. A formulation (BIOF2) for cartilage regeneration has been recently developed. The present study evaluated the effects of BIOF2 on gene expression in human cell cultures, followed by efficacy trials in three OA animal models. Human synovial fluid cells that were exposed to the formulation exhibited increased transcription factor SOX­9 (SOX9; chondrogenic factor) expression, and decreased mimecan (mineralization inducer) and macrophage­stimulating protein receptor (osteoclastogenic factor) expression. The intra­articular application of BIOF2 in the animal models significantly increased cartilage thickness from 12 to 31% at 28 days, compared with articular cartilage treated with saline solution. The articular area and number of chondrocytes additionally increased significantly, maintaining an unaltered chondrocyte/mm2 proportion. Evaluation of the histological architecture additionally displayed a decrease in the grade of articular damage in the groups treated with BIOF2. In conclusion, BIOF2 has proven to be effective for treating OA in animal models, most likely due to SOX9 overexpression in articular cells.

Effects of the buffering capacity of the soil on the mobilization of heavy metals. Equilibrium and kinetics.

Understanding the possible pH-buffering processes is of maximum importance for risk assessment and remediation feasibility studies of heavy-metal contaminated soils. This paper presents the results about the effect of the buffering capacity of a polluted soil, rich in carbonates, on the pH and on the leaching evolution of its main contaminant (lead) when a weak acid (acetic acid) or a strong one (nitric acid) are slowly added. In both cases, the behavior of lead dissolution could be predicted using available (scientifically verified freeware) models assuming equilibrium between the solid and the aqueous phase. However, the experimental results indicate that the dissolution of calcium and magnesium carbonates is kinetically controlled. These kinetic limitations affect the overall behavior, and should be considered to understand also the response of the metals under local equilibrium. The well-known BCR sequential extraction procedure was used before- and after-treatment, to fractionate the lead concentration in the soil according to its mobility. The BCR results were also in agreement with the predictions of the equilibrium model. This agreement allows new insights about the information that could be derived from the BCR fractionation analysis.

A generalized model for transport of contaminants in soil by electric fields.

A generalized model applicable to soils contaminated with multiple species under enhanced boundary conditions during treatment by electric fields is presented. The partial differential equations describing species transport are developed by applying the law of mass conservation to their fluxes. Transport, due to migration, advection and diffusion, of each aqueous component and complex species are combined to produce one partial differential equation that describes transport of the total analytical concentrations of component species which are the primary dependent variables. This transport couples with geochemical reactions such as aqueous equilibrium, sorption, precipitation and dissolution. The enhanced model is used to simulate electrokinetic cleanup of lead and copper contaminants at an Army Firing Range. Acid enhancement is achieved by the use of adipic acid to neutralize the basic front produced for the cathode electrochemical reaction. The model is able to simulate enhanced application of the process by modifying the boundary conditions. The model showed that kinetics of geochemical reactions, such as metals dissolution/leaching and redox reactions, may be significant for realistic prediction of enhanced electrokinetic extraction of metals in real-world applications.

Resultados de tratamiento de infecciones odontogénicas con solución de NaCl superoxidada, electrolizada, de pH neutro / Results of treating odontogenic infections with superoxidized, electrolized, neutral pH NaOCl solution

En la práctica odontológica diaria es tal el afán de resolver satisfactoriamente los problemas que representan las infecciones de cualquier índole, ya sean agudas o crónicas, que al final de cuentas se aceptan o rompen paradigmas con tal de conseguir dicho objetivo. Así, podemos observar, con la historia como testigo, la evolución de los procedimientos terapéuticos para dicho fin